title: [Systemic lupus erythematosus - Standards in 2015].
authors.affiliation: Rheumatologie, Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, TU Dresden.
authors.forename: M
authors.initials: M
authors.lastname: Aringer
authors.affiliation: Poliklinik für Rheumatologie, Heinrich-Heine-Universität Düsseldorf.
authors.forename: M
authors.initials: M
authors.lastname: Schneider
mesh_terms: D000465:Algorithms; D000974:Antibodies, Antinuclear / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use; D034961:Antigens, Nuclear / Q000097:blood; D000962:Antimalarials / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000175:diagnosis / Q000517:prevention & control; D053264:B-Cell Activating Factor / Q000037:antagonists & inhibitors / Q000276:immunology; D003131:Combined Modality Therapy; D042241:Early Diagnosis; D019983:Guideline Adherence / Q000592:standards; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D020945:Lupus Vasculitis, Central Nervous System / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D013473:Sunscreening Agents / Q000627:therapeutic use; D057170:Translational Research, Biomedical; D014611:Vaccination
chemical_list: D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D061067:Antibodies, Monoclonal, Humanized; D034961:Antigens, Nuclear; D000962:Antimalarials; D053264:B-Cell Activating Factor; D013473:Sunscreening Agents; C505719:TNFSF13B protein, human; C511911:belimumab